Citation: | DING Xiaowen, CHEN Feng, XIE Shangnao. Multivariate Analysis of Non-sentinel Lymph Node Status in Breast Cancer Patients with Positive Sentinel Lymph Node[J]. Cancer Research on Prevention and Treatment, 2013, 40(09): 864-868. DOI: 10.3971/j.issn.1000-8578.2013.09.011 |
[1] |
Lyman GH,Giuliano AE,Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer[J].J Clin Oncol,2005,23(30):7703-20.
|
[2] |
Rubio IT,Korourian S,Cowan C, et al. Sentinel lymph node biopsy for staging breast cancer[J].Am J Surg,1998,176(6):532-7.
|
[3] |
Carlson RW,McCormick B.Update:NCCN breast cancer Clinical Practice Guidelines[J].J Natl Compr Canc Netw,2005,3 Suppl 1:S7-11.
|
[4] |
Giuliano AE,Haigh PI,Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer[J].J Clin Oncol,2000,18(13):2553-9.
|
[5] |
Turner RR,Ollila DW,Krasne DL,el al.Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma[J].Ann Surg,1997,226(3):271-6.
|
[6] |
Kamath VJ,Giuliano R,Dauway EL, et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla:a study to evaluate the need for complete axillary lymph node dissection[J].Arch Surg,2001,136(6):688-92.
|
[7] |
Sachdev U,Murphy K,Derzie A, et al. Predictors of nonsentinel lymph node metastasis in breast cancer patients[J].Am J Surg,2002,183(3):213-7.
|
[8] |
Nakhlis F,Golshan M.Bevacizumab:where do we go from here in breast cancer? [J].Transl Cancer Res,2012,1(1):55-6.
|
[9] |
Chen WQ,Zheng RS,Zhang SW, et al. Report of incidence and mortality in China cancer registries,2009[J].Chin J Cancer Res,2013,25(1):10-21.
|
[10] |
Zhang BN,Cao XC,Chen JY, et al. Guidelines on the diagnosis and treatment of breast cancer (2011 edition) [J].Gland Surg,2012,1(1):39-61.
|
[11] |
Rashid OM,Takabe K.The evolution of the role of surgery in the management of breast cancer lung metastasis[J].J Thorac Dis,2012,4(4):420-4.
|
[12] |
Fan F.Sentinel lymph node micrometastases andolated tumor cells in breast cancer:an evolving field[J].Gland Surg,2012,1(1):5-6.
|
[13] |
Bernet L,Cano R.Metastatic sentinel node and axillary lymphadenectomy revisited[J].Gland Surg,2012,1(1):7-8.
|
[14] |
McLaughlin SA,Wright MJ,Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection:objective measurements [J].J Clin Oncol,2008,26(32):5213-9.
|
[15] |
Nelson V,Rademaker A,Kaklamani V.Paradigm of polyendocrine therapy in endocrine responsive breast cancer:the role of fulvestrant[J].Chin Clin Oncol,2013,2(1):10.
|
[16] |
Ashikaga T,Krag DN,Land SR, et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection[J].J Surg Oncol,2010,102(2):111-8.
|
[17] |
Shah-Khan M,Boughey JC.Evolution of axillary nodal staging in breast cancer:clinical implications of the ACOSOG Z0011 Trial[J].Cancer Control,2012,19(4):267-76.
|
[18] |
Andersson Y,Frisell J,de Boniface J, et al. Prediction of non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastases:evaluation of the tenon score[J].Breast Cancer (Auckl),2012,6:31-8.
|
[19] |
Tvedskov TF,Jensen MB,Lisse IM, et al. High risk of non-sentinel node metastases in a group of breast cancer patients with micrometastases in the sentinel node[J].Int J Cancer,2012,131(10):2367-75.
|
[20] |
Meretoja TJ,Strien L,Heikkil PS, et al. A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement[J].Ann Surg Oncol,2012,19(2):567-76.
|
[21] |
Meretoja TJ,Leidenius MH,Heikkil PS, et al. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer[J].J Natl Cancer Inst,2012,104(24):1888-96.
|